Triple

T6311254
Position Surface form Disambiguated ID Type / Status
Subject Novartis E141505 entity
Predicate notableDrug P7501 FINISHED
Object Cosentyx
Cosentyx is a biologic medication (secukinumab) used to treat autoimmune inflammatory conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis.
 E584151 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Cosentyx | Statement: [Novartis, notableDrug, Cosentyx]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Cosentyx
Context triple: [Novartis, notableDrug, Cosentyx]
  • A. Stelara
    Stelara is a prescription biologic medication (ustekinumab) used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and Crohn’s disease by targeting specific immune system pathways.
  • B. Taltz
    Taltz is a prescription biologic medication (ixekizumab) used to treat moderate to severe plaque psoriasis and certain types of arthritis by targeting the inflammatory protein IL-17A.
  • C. Xeljanz
    Xeljanz is an oral Janus kinase (JAK) inhibitor medication used primarily to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
  • D. Dupixent
    Dupixent is a prescription biologic medication (dupilumab) used to treat moderate-to-severe inflammatory conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps.
  • E. Kevzara
    Kevzara is a prescription monoclonal antibody medication (sarilumab) used to treat adults with moderate to severe rheumatoid arthritis by targeting the interleukin-6 (IL-6) receptor.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Cosentyx
Triple: [Novartis, notableDrug, Cosentyx]
Generated description
Cosentyx is a biologic medication (secukinumab) used to treat autoimmune inflammatory conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Cosentyx
Target entity description: Cosentyx is a biologic medication (secukinumab) used to treat autoimmune inflammatory conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis.
  • A. Stelara
    Stelara is a prescription biologic medication (ustekinumab) used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and Crohn’s disease by targeting specific immune system pathways.
  • B. Taltz
    Taltz is a prescription biologic medication (ixekizumab) used to treat moderate to severe plaque psoriasis and certain types of arthritis by targeting the inflammatory protein IL-17A.
  • C. Xeljanz
    Xeljanz is an oral Janus kinase (JAK) inhibitor medication used primarily to treat autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
  • D. Dupixent
    Dupixent is a prescription biologic medication (dupilumab) used to treat moderate-to-severe inflammatory conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps.
  • E. Kevzara
    Kevzara is a prescription monoclonal antibody medication (sarilumab) used to treat adults with moderate to severe rheumatoid arthritis by targeting the interleukin-6 (IL-6) receptor.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c008d00efc8190a36c05b4b4a3bf4b completed March 22, 2026, 3:20 p.m.
NER Named-entity recognition batch_69c0649d1e048190a3fc7fbce9d2ee57 completed March 22, 2026, 9:52 p.m.
NED1 Entity disambiguation (via context triple) batch_69c5e461e2ec8190af7198a03edb1ff7 completed March 27, 2026, 1:58 a.m.
NEDg Description generation batch_69c5e66e8b3c8190bd4cd960b91de473 completed March 27, 2026, 2:07 a.m.
NED2 Entity disambiguation (via description) batch_69c5e6e40c588190898ad952b71e5b11 completed March 27, 2026, 2:09 a.m.
Created at: March 22, 2026, 4:28 p.m.